Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
50.5 EUR | 0.00% | +1.41% | +35.75% |
06-20 | Berenberg Lifts Price Target on Lonza Group, Maintains Buy Recommendation | MT |
05-14 | Swiss Market Index Edges Up Ahead of Inflation Report | MT |
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's high margin levels account for strong profits.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- With an expected P/E ratio at 40.12 and 32.04 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Sector: Biotechnology & Medical Research
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+35.75% | 38.13B | - | ||
+19.41% | 45.51B | B- | ||
-8.62% | 38.52B | B | ||
+26.95% | 30.74B | B | ||
-13.50% | 26.03B | C | ||
+10.74% | 25.92B | B- | ||
+44.87% | 14.13B | B+ | ||
+34.36% | 12.73B | C+ | ||
-7.14% | 11.29B | B+ | ||
-12.61% | 10.64B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- LONN Stock
- LO3A Stock
- Ratings Lonza Group AG